US 8008316
Azonafide derived tumor and cancer targeting compounds
granted A61PA61P35/00
Quick answer
US patent 8008316 (Azonafide derived tumor and cancer targeting compounds) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Aug 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61P, A61P35/00